{
    "Trade/Device Name(s)": [
        "Plexus EBV IgG Multi-Analyte Diagnostics"
    ],
    "Submitter Information": "Focus Diagnostics, Inc.",
    "510(k) Number": "K073382",
    "Predicate Device Reference 510(k) Number(s)": [],
    "Regulatory Class": "Class I",
    "Product Code(s)": [
        "LSE"
    ],
    "Summary Letter Date": "November 30, 2007",
    "Summary Letter Received Date": "December 3, 2007",
    "Submission Date": "November 30, 2007",
    "Regulation Number(s)": [
        "21 CFR 866.3235"
    ],
    "Regulation Name(s)": [
        "Epstein-Barr Virus Serological Device"
    ],
    "Analyte Class(es)": [
        "virology",
        "immunology",
        "serology"
    ],
    "Analyte(s)": [
        "Epstein-Barr virus IgG antibodies",
        "Viral Capsid Antigen (VCA)",
        "Early Antigen - Diffuse (EA-D)",
        "Nuclear Antigen (EBNA-1)"
    ],
    "Specimen Type(s)": [
        "Serum"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Luminex XMAP technology",
        "Plexus software"
    ],
    "Method(s)/Technology(ies)": [
        "Multiplex Microbead Immunoassay (MMIA)",
        "Fluorescence detection"
    ],
    "Methodologies": [
        "Multiplex Microbead Immunoassay"
    ],
    "Submission Type(s)": [
        "Kit",
        "Assay"
    ],
    "Document Summary": "FDA 510(k) summary for Plexus EBV IgG Multi-Analyte Diagnostics kit detecting IgG antibodies to Epstein-Barr virus antigens via multiplex microbead immunoassay",
    "Indications for Use Summary": "Qualitative detection of human IgG antibodies to EBV antigens (VCA, EA-D, EBNA-1) in serum as an aid in the diagnosis of EBV infection and EBV-associated infectious mononucleosis",
    "fda_folder": "Microbiology"
}